Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.

Nokin MJ, Darbo E, Travert C, Drogat B, Lacouture A, San José S, Cabrera N, Turcq B, Prouzet-Mauleon V, Falcone M, Villanueva A, Wang H, Herfs M, Mosteiro M, Jänne PA, Pujol JL, Maraver A, Barbacid M, Nadal E, Santamaría D, Ambrogio C

Open source

DOI: 10.1172/jci.insight.137869
Published: 2020 Aug 6
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.137869,
  title = {Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.},
  author = {Nokin MJ and Darbo E and Travert C and Drogat B and Lacouture A and San José S and Cabrera N and Turcq B and Prouzet-Mauleon V and Falcone M and Villanueva A and Wang H and Herfs M and Mosteiro M and Jänne PA and Pujol JL and Maraver A and Barbacid M and Nadal E and Santamaría D and Ambrogio C},
  year = {2020},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.137869},
  url = {https://doi.org/10.1172/jci.insight.137869}
}

RIS

TY  - JOUR
TI  - Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
AU  - Nokin MJ
AU  - Darbo E
AU  - Travert C
AU  - Drogat B
AU  - Lacouture A
AU  - San José S
AU  - Cabrera N
AU  - Turcq B
AU  - Prouzet-Mauleon V
AU  - Falcone M
AU  - Villanueva A
AU  - Wang H
AU  - Herfs M
AU  - Mosteiro M
AU  - Jänne PA
AU  - Pujol JL
AU  - Maraver A
AU  - Barbacid M
AU  - Nadal E
AU  - Santamaría D
AU  - Ambrogio C
PY  - 2020
JO  - JCI insight
DO  - 10.1172/jci.insight.137869
UR  - https://doi.org/10.1172/jci.insight.137869
ER  -

APA

MJ, N., E, D., C, T., B, D., A, L., S, S. J., N, C., B, T., V, P., M, F., A, V., H, W., M, H., M, M., PA, J., JL, P., A, M., M, B., E, N., D, S., & C, A. (2020). Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.. JCI insight. https://doi.org/10.1172/jci.insight.137869

Source records

pubmed · retrieved 2026-09-27T13:10:19.595Z